X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Wockhardt with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs ACTAVIS (US) - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT LTD.   ACTAVIS
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-18
ACTAVIS
Dec-14
WOCKHARDT LTD./
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,01219,647-   
Low Rs53211,984-   
Sales per share (Unadj.) Rs355.93,537.9-  
Earnings per share (Unadj.) Rs-60.3-441.5-  
Cash flow per share (Unadj.) Rs-46.8324.6-  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.87,673.6-  
Shares outstanding (eoy) m110.63265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.5 48.5%   
Avg P/E ratio x-12.8-35.8 35.7%  
P/CF ratio (eoy) x-16.548.7 -33.9%  
Price / Book Value ratio x3.02.1 145.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,3794,205,366 2.0%   
No. of employees `0006.321.6 29.0%   
Total wages/salary Rs m9,3710-   
Avg. sales/employee Rs Th6,295.043,552.1 14.5%   
Avg. wages/employee Rs Th1,498.30-   
Avg. net profit/employee Rs Th-1,066.3-5,434.8 19.6%   
INCOME DATA
Net Sales Rs m39,369940,725 4.2%  
Other income Rs m1,202-2,348 -51.2%   
Total revenues Rs m40,571938,377 4.3%   
Gross profit Rs m18120,850 0.0%  
Depreciation Rs m1,495203,701 0.7%   
Interest Rs m2,55529,672 8.6%   
Profit before tax Rs m-2,830-114,872 2.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,582-8,426 42.5%   
Tax Rs m257-5,906 -4.4%   
Profit after tax Rs m-6,669-117,393 5.7%  
Gross profit margin %012.8 0.4%  
Effective tax rate %-9.15.1 -176.7%   
Net profit margin %-16.9-12.5 135.7%  
BALANCE SHEET DATA
Current assets Rs m33,796495,642 6.8%   
Current liabilities Rs m26,917361,468 7.4%   
Net working cap to sales %17.514.3 122.5%  
Current ratio x1.31.4 91.6%  
Inventory Days Days7958 136.8%  
Debtors Days Days8966 134.6%  
Net fixed assets Rs m39,664114,872 34.5%   
Share capital Rs m5530-   
"Free" reserves Rs m27,9680-   
Net worth Rs m28,5222,040,399 1.4%   
Long term debt Rs m21,7311,069,209 2.0%   
Total assets Rs m81,6203,739,379 2.2%  
Interest coverage x-0.1-2.9 3.7%   
Debt to equity ratio x0.80.5 145.4%  
Sales to assets ratio x0.50.3 191.7%   
Return on assets %-5.0-2.3 214.8%  
Return on equity %-23.4-5.8 406.4%  
Return on capital %-7.7-3.0 254.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,0190-   
CASH FLOW
From Operations Rs m684161,541 0.4%  
From Investments Rs m6,302-386,791 -1.6%  
From Financial Activity Rs m-7,695217,320 -3.5%  
Net Cashflow Rs m-664-7,929 8.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.02 Rs / USD

Compare WOCKHARDT LTD. With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare WOCKHARDT LTD. With: STERLING BIOTECH  NATCO PHARMA  GSK PHARMA  PFIZER  TTK HEALTHCARE  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views On News

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Dec 14, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - DR. REDDYS LAB COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS